Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 620, pseudogene (RN7SL620P)

Target
RN7SL620P
Molecular classification
Pseudogene, Non-coding RNA (ncRNA), 7SL RNA pseudogene
01

Overview

RN7SL620P, also known as RNA, 7SL, cytoplasmic 620, pseudogene, is a member of the large family of 7SL RNA pseudogenes in the human genome[1][5][7]. The canonical 7SL RNA is an essential non-coding RNA component of the signal recognition particle (SRP), which plays a central role in directing newly synthesized secretory and membrane proteins to the endoplasmic reticulum[3][8]. However, RN7SL620P itself is a pseudogene: it is a non-functional, non-coding genetic element derived from the retrotransposition or duplication of the functional 7SL RNA gene. Most 7SL pseudogenes are not transcribed to stable RNA or protein, and RN7SL620P is not known to produce a functional transcript or have physiological or pathological function[1][5][7]. As such, it is not a therapeutic target, nor is it associated with any drugs, mechanisms, or biomarker status. While a minority of pseudogenes in other contexts may exert regulatory effects (such as acting as miRNA decoys or transcriptional regulators), there is no evidence that RN7SL620P has such functions[4][6].

Other names
RN7SL620P7SL RNA pseudogene 620RNA, 7SL, cytoplasmic 620 pseudogene
02

Biological functions

Pseudogenes generally do not have a biological function, but some may act as regulatory RNAs (e.g., miRNA sponges or competing endogenous RNAs in rare cases[4][6])
03

Disease associations

Other (no specific, well-characterized disease associations for RN7SL620P; in rare cases, pseudogenes have regulatory or biomarker roles[6][8])

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 620, pseudogene (RN7SL620P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 620, pseudogene (RN7SL620P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call